PL2099740T3 - Sposób wytwarzania optycznie czystego R(-) salbutamolu oraz ich farmaceutycznie dopuszczalnych soli - Google Patents

Sposób wytwarzania optycznie czystego R(-) salbutamolu oraz ich farmaceutycznie dopuszczalnych soli

Info

Publication number
PL2099740T3
PL2099740T3 PL06842766T PL06842766T PL2099740T3 PL 2099740 T3 PL2099740 T3 PL 2099740T3 PL 06842766 T PL06842766 T PL 06842766T PL 06842766 T PL06842766 T PL 06842766T PL 2099740 T3 PL2099740 T3 PL 2099740T3
Authority
PL
Poland
Prior art keywords
salbutamol
preparation
pharmaceutically acceptable
acceptable salts
optically pure
Prior art date
Application number
PL06842766T
Other languages
English (en)
Inventor
Parimal Hansmukh Desai
Narendra Jagannath Salvi
Bharatkumar Surendra Patravale
Subramanian Seetharaman
Dilip Jibhau Patil
Khandu Shankar Ghogare
Original Assignee
Aarti Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aarti Healthcare Ltd filed Critical Aarti Healthcare Ltd
Publication of PL2099740T3 publication Critical patent/PL2099740T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06842766T 2006-08-02 2006-09-25 Sposób wytwarzania optycznie czystego R(-) salbutamolu oraz ich farmaceutycznie dopuszczalnych soli PL2099740T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1221MU2006 2006-08-02
EP06842766.5A EP2099740B1 (en) 2006-08-02 2006-09-25 A process for the preparation of optically pure r (-) salbutamol and its pharmaceutically acceptable salts
PCT/IN2006/000391 WO2008015689A1 (en) 2006-08-02 2006-09-25 A process for the preparation of optically pure r (-) salbutamol and its pharmaceutically acceptable salts

Publications (1)

Publication Number Publication Date
PL2099740T3 true PL2099740T3 (pl) 2014-01-31

Family

ID=37907375

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06842766T PL2099740T3 (pl) 2006-08-02 2006-09-25 Sposób wytwarzania optycznie czystego R(-) salbutamolu oraz ich farmaceutycznie dopuszczalnych soli

Country Status (5)

Country Link
US (1) US8063251B2 (pl)
EP (1) EP2099740B1 (pl)
ES (1) ES2431844T3 (pl)
PL (1) PL2099740T3 (pl)
WO (1) WO2008015689A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103896783A (zh) * 2012-12-27 2014-07-02 重庆华邦制药有限公司 左沙丁胺醇衍生物右旋杂质的回收利用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617238A (ja) * 1984-06-21 1986-01-13 Kongo Kagaku Kk ｄｌ−クロルプレナリンの光学分割法
US5442118A (en) 1994-04-22 1995-08-15 Sepracor, Inc. Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones
US5399765A (en) 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5545745A (en) 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
EP1056740A1 (en) 1998-02-20 2000-12-06 Fine Chemicals Corporation (Proprietary) Limited Process for the production of optically enriched (r)- or (s)-albuterol
GB0030171D0 (en) 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol
US7049469B2 (en) 2002-10-24 2006-05-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing (R)-salbutamol
WO2005113481A1 (en) 2004-05-20 2005-12-01 Teva Pharmaceutical Fine Chemicals S.R.L. Preparation of levalbuterol hydrochloride

Also Published As

Publication number Publication date
EP2099740A1 (en) 2009-09-16
US8063251B2 (en) 2011-11-22
EP2099740B1 (en) 2013-08-14
ES2431844T3 (es) 2013-11-28
US20100204516A1 (en) 2010-08-12
WO2008015689A1 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
EP2086945A4 (en) NOVEL PROCESS FOR THE PRODUCTION OF STATINES AND THEIR PHARMACEUTICAL ACCEPTIC SALTS
IL196234A0 (en) A process for the preparation of optically active cyclopropylamines
IL206500A0 (en) Process for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
SI2024341T1 (sl) Novi postopek za statine in njihove farmacevtsko sprejemljive soli
IL196854A (en) Indole compounds and their appropriate pharmaceutical salts and their use in the preparation of @ drugs
DE602007002909D1 (de) Geschoss zur verabreichung eines medikaments
AP1821A (en) New process for the synthesis of ivabradine and additional salts thereof with a pharmaceutically acceptable acid
ZA200808631B (en) Solid oral form of a medicinal preparation and a method for the production thereof
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
EP2035410A4 (en) PROCESS FOR PREPARING ESOMEPRAZOLE AND ITS SALTS
ZA200906899B (en) Process for preparation of erlotinib and its pharmaceutically acceptable salts
EP2039689A4 (en) PROCESS FOR PREPARING OPTICALLY ACTIVE 3-AMINO-2-HYDROXYPROPIONIC ACID CYCLOPROPYLAMID DERIVATIVES AND SALTS THEREOF
HK1145833A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
EP2069329A4 (en) PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND THEIR SALTS
EP2123628A4 (en) PROCESS FOR THE PREPARATION OF OPTICALLY PURE MILNACIPRAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
PL3067353T3 (pl) Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania
HK1126221A1 (en) Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group
PL1848419T3 (pl) Preparaty diklofenaku i jego farmaceutycznie dopuszczalnych soli do wstrzykiwań
ZA200902575B (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
PL2291374T3 (pl) Sposób wytwarzania solifenacyny i/lub jej farmaceutycznie dopuszczalnych soli o wysokiej czystości farmaceutycznej
IL192602A (en) Use of theotropium salts for the preparation of a drug for the treatment of asthma in severe stage 3 gina
EP2077822A4 (en) ORAL FORMULATION CONTAINING OXCARBAZEPINE AND METHOD FOR PRODUCING THE SAME
EP2121729A4 (en) PHARMACEUTICAL, SUBSTANTIVE SALTS OF THYMODEPRESSINE AND METHOD FOR THE PRODUCTION THEREOF
PL2099740T3 (pl) Sposób wytwarzania optycznie czystego R(-) salbutamolu oraz ich farmaceutycznie dopuszczalnych soli
IL222788A (en) Processes for the preparation of zilpatrol and its salts, zilpatrol and its salts prepared in these processes and their use in the preparation of a drug